Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine Infusion Regimens in CRPS
NCT05997134Phase 4Unknown
- Sponsor
- Tanta University
- Start
- Aug 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ketamine in complex regional pain syndrome (CRPS) (3 arms), sponsored by Tanta University. Primary endpoint: Degree of chronic pain reduction at 3 months. Status: unknown.
02
Drugs
ketamine
03
Conditions
complex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on NCT05997134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05997134.